Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease

Blood

Volumn 107, Issue 8, 2006, Pages 3350-3358

  Grosse, Johannes ^b   Chitu, Violeta ^b   Marquardt, Andreas ^b   Hanke, Petra ^b   Schmittwolf, Carolin ^b   Zeitlmann, Lutz ^b   Schropp, Patricia ^b   Barth, Bettina ^b   Yu, Philipp ^b   Paffenholz, Rainer ^b   Stumm, Gabriele ^b   Nehls, Michael ^b   Stanley, E Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CLODRONIC ACID; CYTOKINE; LIPOPOLYSACCHARIDE; LIPOSOME; MACROPHAGE ACTIN ASSOCIATED TYROSINE PHOSPHORYLATED PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MUTANT PROTEIN; PROLINE SERINE THREONINE PHOSPHATASE INTERACTING PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOINFLAMMATORY DISEASE; BONE MARROW TRANSPLANTATION; CHEMICAL MUTAGENESIS; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG EFFECT; EAR; FEMALE; GENE MUTATION; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOLECULAR CLONING; MONOCYTE; MOUSE; MOUSE MUTANT; NECROSIS; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OSTEOLYSIS; PATHOGENESIS; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RECESSIVE GENE; WILD TYPE;

EID: 33645734214     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-09-3556     Document Type: Article

References (51)

1. Galon J, Aksentijevich I, McDermott MF, O'Shea JJ, Kastner DL. TNFRSF1A mutations and autoinflammatory syndromes. Curr Opin Immunol. 2000;12:479-486.
2. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133-144.
3. Hull KM, Drewe E, Aksentijevich I, et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore). 2002;81:349-368.
4. McDermott MF. A common pathway in periodic fever syndromes. Trends Immunol. 2004;25:457-460.
5. Spencer S, Dowbenko D, Cheng J, et al. PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase. J Cell Biol. 1997;138:845-860.
6. Wise CA, Gillum JD, Seidman CE, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 2002;11:961-969.
7. Dowbenko D, Spencer S, Quan C, Lasky L. Identification of a novel polyproline recognition site in the cytoskeletal associated protein, proline serine threonine phosphatase interacting protein. J Biol Chem. 1998;273:989-996.
8. Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A. 2003;100:13501-13506.
9. Lippincott J, Li R. Involvement of PCH family proteins in cytokinesis and actin distribution. Microsc Res Tech. 2000;49:168-172.
10. Wu Y, Spencer SD, Lasky LA. Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. J Biol Chem. 1998;273:5765-5770.
11. Yeung YG, Soldera S, Stanley ER. A novel macrophage actin-associated protein (MAYP) is tyrosine-phosphorylated following colony stimulating factor-1 stimulation. J Biol Chem. 1998;273:30638-30642.
12. Wu Y, Dowbenko D, Lasky LK. PSTPIP 2, a second tyrosine phosphorylated, cytoskeletal associated protein that binds a PEST-type proteintyrosine phosphatase. J Biol Chem. 1998;273:30487-30496.
13. Ho HY, Rohatgi R, Lebensohn AM, et al. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell. 2004;118:203-216.
14. Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J Biol Chem. 2000;275:7854-7861.
15. Chitu V, Pixley FJ, Macaluso F, et al. The PCH family member MAYP/PSTPIP2 directly regulates F-actin bundling and enhances filopodia formation and motility in macrophages. Mol Biol Cell. 2005;16:2947-2959.
16. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004;14:628-638.
17. Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36:20-42.
18. Augustin M. Efficient and fast targeted production of murine models based on chemical mutagenesis. Mamm Genome. 2005;16:405-413.
19. Yu P, Constien R, Dear N, et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity. 2005;22:451-465.
20. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
21. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002;99:111-120.
22. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol. 1976;(suppl 5):9-15.
23. Stanley ER. Murine bone marrow-derived macrophages. In: Walker JM, Pollard JW, eds. Animal Cell Culture. 2nd ed. Totowa, NJ: Humana Press; 1997:301-304.
24. Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Warner JR, Stanley ER. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell. 1982;28:71-81.
25. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869-877.
26. Guilbert LJ, Stanley ER. Specific interaction of murine colony-stimulating factor with mononuclear phagocytic cells. J Cell Biol. 1980;85:153-159.
27. Biermann H, Pietz B, Dreier R, Schmid KW, Sorg C, Sunderkötter C. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leuk Biol. 1999;65:217-231.
28. van Rooijen N, van Kesteren-Hendrikx E. Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res. 2002;12:81-94.
29. Buhles WC Jr. Studies on mononuclear phagocyte progenitor cells: morphology of cells and colonies in liquid culture of mouse bone marrow. J Reticuloendothel Soc. 1979;25:363-378.
30. Pels E, De Groot JW, Mullink R, Van Unnik JA, den Otter W. Identification of two different types of mouse peritoneal exudate cells with ring-shaped nuclei. J Reticuloendothel Soc. 1980;27:367-376.
31. Bertin J, DiStefano PS. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 2000;7:1273-1274.
32. Martinon F, Hofmann K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol. 2001;11:R118-R120.
33. Wang L, Manji GA, Grenier JM, et al. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem. 2002;277:29874-29880.
34. Manji GA, Wang L, Geddes BJ, et al. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NFkappa B. J Biol Chem. 2002;277:11570-11575.
35. Chae JJ, Komarow HD, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591-604.
36. Côté JF, Charest A, Wagner J, Tremblay ML. Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. Biochemistry. 1998;37:13128-13137.
37. Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002;20:409-419.
38. Cortis E, De Benedetti F, Insalaco A, et al. Abnormal production of tumor necrosis factor (TNF) alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [published correction appears in J Pediatr. 2005;146:193]. J Pediatr. 2004;145:851-855.
39. Stichweh DS, Punaro M, Pascual V. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol. 2005;22:262-265.
40. Yoshimura T, Leonard EJ. Human monocyte chemoattractant protein-1: structure and function. Cytokines. 1992;4:131-152.
41. Kim MS, Day CJ, Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-κB ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem. 2005;280:16163-16169.
42. Hashimoto Y, Arai I, Nakanishi Y, Sakurai T, Nakamura A, Nakaike S. Scratching of their skin by NC/Nga mice leads to development of dermatitis. Life Sci. 2004;76:783-794.
43. Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 1997;9:461-466.
44. Cole KE, Strick CA, Paradis TJ, et al. Interferoninducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187:2009-2021.
45. Goya I, Gutierrez J, Varona R, Kremer L, Zaballos A, Marquez G. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. J Immunol. 1998;160:1975-1981.
46. Descamps FJ, Van den Steen PE, Nelissen I, Van Damme J, Opdenakker G. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes. Adv Exp Med Biol. 2003;535:69-77.
47. Merriman TR, Cordell HJ, Eaves IA, et al. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes. 2001;50:184-194.
48. Golla A, Jansson A, Ramser J, et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur J Hum Genet. 2002;10:217-221.
49. Rosen P, Hopkin RJ, Glass DN, Graham TB. Another patient with chromosome 18 deletion syndrome and juvenile rheumatoid arthritis. J Rheumatol. 2004;31:998-1000.
50. Byrd L, Grossmann M, Potter M, Shen-Ong GL. Chronic multifocal osteomyelitis, a new recessive mutation on chromosome 18 of the mouse. Genomics. 1991;11:794-798.
51. Ferguson PJ, Bing X, Vasef MA, et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone. 2006;38:41-47.